PCSK5
Proprotein convertase subtilisin/kexin type 5
Also known as: PC5, PC6, PCSK5_HUMAN, SPC6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92824
- Gene
- PCSK5
- Ensembl
- ENSG00000099139
- Chromosome
- 9
- Canonical length
- 1860 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an initial autocatalytic processing event in the ER to generate a heterodimer which exits the ER. It then sorts to the trans-Golgi network where a second autocatalytic event takes place and the catalytic activity is acquired. This encoded protein is widely expressed and one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It mediates posttranslational endoproteolytic processing for several integrin alpha subunits and is thought to process prorenin, pro-membrane type-1 matrix metalloproteinase and HIV-1 glycoprotein gp160. Alternative splicing results in multiple transcript variants, some of which encode distinct isoforms, including a protease packaged into dense core granules (PC5A) and a type 1 membrane bound protease (PC5B). [provided by RefSeq, May 2014]
Canonical amino-acid sequenceUniProt
1860 residues, UniProt reviewed canonical sequence.
>Q92824|PCSK5
1 MGWGSRCCCP GRLDLLCVLA LLGGCLLPVC RTRVYTNHWA VKIAGGFPEA NRIASKYGFI
61 NIGQIGALKD YYHFYHSRTI KRSVISSRGT HSFISMEPKV EWIQQQVVKK RTKRDYDFSR
121 AQSTYFNDPK WPSMWYMHCS DNTHPCQSDM NIEGAWKRGY TGKNIVVTIL DDGIERTHPD
181 LMQNYDALAS CDVNGNDLDP MPRYDASNEN KHGTRCAGEV AAAANNSHCT VGIAFNAKIG
241 GVRMLDGDVT DMVEAKSVSF NPQHVHIYSA SWGPDDDGKT VDGPAPLTRQ AFENGVRMGR
301 RGLGSVFVWA SGNGGRSKDH CSCDGYTNSI YTISISSTAE SGKKPWYLEE CSSTLATTYS
361 SGESYDKKII TTDLRQRCTD NHTGTSASAP MAAGIIALAL EANPFLTWRD VQHVIVRTSR
421 AGHLNANDWK TNAAGFKVSH LYGFGLMDAE AMVMEAEKWT TVPRQHVCVE STDRQIKTIR
481 PNSAVRSIYK ASGCSDNPNR HVNYLEHVVV RITITHPRRG DLAIYLTSPS GTRSQLLANR
541 LFDHSMEGFK NWEFMTIHCW GERAAGDWVL EVYDTPSQLR NFKTPGKLKE WSLVLYGTSV
601 QPYSPTNEFP KVERFRYSRV EDPTDDYGTE DYAGPCDPEC SEVGCDGPGP DHCNDCLHYY
661 YKLKNNTRIC VSSCPPGHYH ADKKRCRKCA PNCESCFGSH GDQCMSCKYG YFLNEETNSC
721 VTHCPDGSYQ DTKKNLCRKC SENCKTCTEF HNCTECRDGL SLQGSRCSVS CEDGRYFNGQ
781 DCQPCHRFCA TCAGAGADGC INCTEGYFME DGRCVQSCSI SYYFDHSSEN GYKSCKKCDI
841 SCLTCNGPGF KNCTSCPSGY LLDLGMCQMG AICKDGEYVD EHGHCQTCEA SCAKCQGPTQ
901 EDCTTCPMTR IFDDGRCVSN CPSWKFEFEN QCHPCHHTCQ RCQGSGPTHC TSCGADNYGR
961 EHFLYQGECG DSCPEGHYAT EGNTCLPCPD NCELCHSVHV CTRCMKGYFI APTNHTCQKL
1021 ECGQGEVQDP DYEECVPCEE GCLGCSLDDP GTCTSCAMGY YRFDHHCYKT CPEKTYSEEV
1081 ECKACDSNCG SCDQNGCYWC EEGFFLLGGS CVRKCGPGFY GDQEMGECES CHRACETCTG
1141 PGHDECSSCQ EGLQLLRGMC VHATKTQEEG KFWNDILRKL QPCHSSCKTC NGSATLCTSC
1201 PKGAYLLAQA CVSSCPQGTW PSVRSGSCEN CTEACAICSG ADLCKKCQMQ PGHPLFLHEG
1261 RCYSKCPEGS YAEDGICERC SSPCRTCEGN ATNCHSCEGG HVLHHGVCQE NCPERHVAVK
1321 GVCKHCPEMC QDCIHEKTCK ECTPEFFLHD DMCHQSCPRG FYADSRHCVP CHKDCLECSG
1381 PKADDCELCL ESSWVLYDGL CLEECPAGTY YEKETKECRD CHKSCLTCSS SGTCTTCQKG
1441 LIMNPRGSCM ANEKCSPSEY WDEDAPGCKP CHVKCFHCMG PAEDQCQTCP MNSLLLNTTC
1501 VKDCPEGYYA DEDSNRCAHC HSSCRTCEGR HSRQCHSCRP GWFQLGKECL LQCREGYYAD
1561 NSTGRCERCN RSCKGCQGPR PTDCLSCDRF FFLLRSKGEC HRSCPDHYYV EQSTQTCERC
1621 HPTCDQCKGK GALNCLSCVW SYHLMGGICT SDCLVGEYRV GEGEKFNCEK CHESCMECKG
1681 PGAKNCTLCP ANLVLHMDDS HCLHCCNTSD PPSAQECCDC QDTTDECILR TSKVRPATEH
1741 FKTALFITSS MMLVLLLGAA VVVWKKSRGR VQPAAKAGYE KLADPNKSYS SYKSSYREST
1801 SFEEDQVIEY RDRDYDEDDD DDIVYMGQDG TVYRKFKYGL LDDDDIDELE YDDESYSYYQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCSK5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 24 nTPM
- duodenum: 23 nTPM
- adipose tissue: 15 nTPM
- ovary: 12 nTPM
- blood vessel: 12 nTPM
- colon: 9 nTPM
Single-cell type
- enterocytes: 1,868 nCPM
- esophageal apical cells: 793 nCPM
- bergmann glia: 701 nCPM
- retinal horizontal cells: 675 nCPM
- ocular epithelial cells: 659 nCPM
- colonocytes: 578 nCPM
Immune cell
- naive CD8 T-cell: 4.9 nTPM
- gdT-cell: 2.6 nTPM
- total PBMC: 2.1 nTPM
- naive CD4 T-cell: 1.6 nTPM
- NK-cell: 1.6 nTPM
- memory CD8 T-cell: 1.3 nTPM
Brain region
- cerebral cortex: 9 nTPM
- hypothalamus: 8.3 nTPM
- basal ganglia: 7.6 nTPM
- hippocampal formation: 6.8 nTPM
- pons: 6.7 nTPM
- medulla oblongata: 6.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.57
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- cell-cell signaling
- cholesterol homeostasis
- cytokine precursor processing
- embryo implantation
- embryonic digestive tract development
- embryonic skeletal system development
- heart development
- kidney development
- limb morphogenesis
- negative regulation of low-density lipoprotein particle receptor catabolic process
- peptide biosynthetic process
- peptide hormone processing
- plasma lipoprotein particle remodeling
- protein processing
- renin secretion into blood stream
- respiratory tube development
- viral life cycle
Molecular functions
- endopeptidase activity
- endopeptidase inhibitor activity
- peptidase activity
- peptide binding
- serine-type endopeptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S8/S53 domain
- EGF-like domain
- P domain
- Furin-like repeat
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- Peptidase S8, subtilisin-related
- Peptidase S8, subtilisin, His-active site
- Peptidase S8, subtilisin, Asp-active site
- Peptidase S8, subtilisin, Ser-active site
- Growth factor receptor domain 4
- Peptidase S8, pro-domain
- Kexin/furin catalytic domain
- Peptidase S8/S53 domain superfamily
- Peptidase S8, pro-domain superfamily
- Subtilase family
- Proprotein convertase P-domain
- Growth factor receptor domain IV
- Peptidase S8 pro-domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCSK5 as an antibody target. Whether an autoantibody or antibody against PCSK5 could matter depends on whether native PCSK5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCSK5 is annotated as secreted, so native PCSK5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PCSK5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...